Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

A Importância do Conhecimento da Rede de Cuidado no Combate ao Estigma da Hanseníase

Aparecida Bazilio V, Wellichan MM, Rodrigo Viana Andrade G, et al. Intermedius-Revista de Extensão da UNIFIMES. 2024;
Download PDF
Publication

Morbimortalidade por Reações em Hanseníase

Ribeiro Filha Coriolano C. Universidade de Brasília. Faculdade de Ciências da Saúde. 2021;
Download PDF
Publication

Quality of Life, Functionality, and Self-Concept of People Post-Discharge from Leprosy

Fortunato CN, Nogueira JDA, Brito KKGD, et al. Cogitare Enfermagem. 2024;
Download PDF
Publication

Karakteristik Penderita Lepra (kusta) yang Menjalani Pengobatan Rawat Jalan di Puskesmas Tamalate Makassar Periode 2017 - 2022

Pratama Mahfud M, Yuniati L, Adharia A, et al. Jurnal Pendidikan Tambusai. 2024;
Download PDF
Publication

Lepra: una enfermedad de la piel olvidada

Delfino Castillo Solana A, Romero Navarrete M. Dermatol Rev Mex. 2024;
Download PDF
Publication

Manifestaciones faríngeas y nasales en un paciente con lepra lepromatosa

Hernández Peña O, López Rodríguez EB, Veitía Corrales G, et al. Revista Cubana de Otorrinolaringología y Cirugía de Cabeza y Cuello. 2024;
Download PDF
Publication

Caracterización de pacientes con lepra en el municipio Holguín de 2017 a 2022

Infante Gómez DM, Benítez Cedeño E, Chacón Bonet D, et al. Correo Científico Médico (CCM). 2024;
Download PDF
Publication

On the Physical and Ethnological Conditions under Which Leprosy Occurs in China, the Malay Peninsula, the East Indian Archipelago, and the Islands of the Pacific.

Cantlie J. Transactions. Epidemiological Society of London. 1898;
Download PDF
Publication

Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR)

Penna GO, Pontes MADA, Talhari S, et al. Elsevier BV. The Brazilian Journal of Infectious Diseases. 2024; 28 (2) : 1-8.
Download PDF
Publication

Relationship between knowledge level and compliance with leprosy treatment

Sukardi Jaya V, Sunarti , Suryani D. Science Midwifery. 2024;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 92
  • Next page ››
Subscribe to Leprosy (Hansen disease)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD